High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?
Author:
Affiliation:
1. Institute of Hematology; Davidoff Cancer Center, Rabin Medical Center; Petah Tikva Israel
2. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel
3. Leukemia Service; Memorial Sloan Kettering Cancer Center; New York NY USA
Publisher
Wiley
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference30 articles.
1. The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature;Leopold;Leuk Lymphoma,2002
2. Salvage therapy for relapsed or refractory acute myeloid leukemia;Mangan;Ther Adv Hematol,2011
3. Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine;Raanani;Leuk Res,1999
4. International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia;Roboz;J Clin Oncol,2014
5. Problems related to resistance to cytarabine in acute myeloid leukemia;Cros;Leuk Lymphoma,2004
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations;Pharmaceutics;2021-10-02
2. Management of Relapsed/Refractory Acute Myeloid Leukemia;Acute Leukemias;2020-10-11
3. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase;Nucleosides, Nucleotides & Nucleic Acids;2020-07-30
4. FEBRILE NEUTROPENIA IN ACUTE LEUKEMIA. EPIDEMIOLOGY, ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT;Mediterranean Journal of Hematology and Infectious Diseases;2019-12-30
5. A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells;Medical Oncology;2019-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3